While GLP-1 receptor agonists have been extensively studied for blood sugar and weight control, new research highlights their broader effectsespecially at lower doses: Cognitive Function & Brain Health A 2021 study published in Life Sciences found that GLP-1 medication reduced both systemic and central nervous system inflammation in a rodent model
Wegovy has been exclusively approved for weight management
FIGURE 4 Darinaparsin was characterized in vitro as a potent inducer of growth arrest and apoptosis in a range of hematologic malignancies such as acute promyelocytic leukemia (APL), acute lymphoblastic leukemia, B cell lymphoma, and multiple myeloma (Diaz et al., 2008
& Mahajan, R
This leads to significant metabolic effects, including improved insulin sensitivity, reduced glucose levels, and increased energy expenditure
Increased Risk of Adverse Side Effects Both semaglutide and tirzepatide share common gastrointestinal side effects, including nausea, vomiting, diarrhea, and constipation